Mandate

Vinge advises TA Associates together with Goodwin Procter in connection with acquisition

August 23, 2023 M&A

Leading global private equity firms TA Associates and Warburg Pincus LLC have entered into an agreement to acquire a majority stake in Epassi Group from majority shareholder Bregal Milestone. Vinge acted as counsel to TA Associates with respect to Swedish matters in the transaction. Vinge advised TA Associates alongside Goodwin Procter.

Leading global private equity firms TA Associates and Warburg Pincus LLC have entered into an agreement to acquire a majority stake in Epassi Group from majority shareholder Bregal Milestone. Vinge acted as counsel to TA Associates with respect to Swedish matters in the transaction. Vinge advised TA Associates alongside Goodwin Procter.

TA is a leading global private equity firm focused on scaling growth in profitable companies. Warburg Pincus is a leading global growth investor and an experienced partner to management teams seeking to build durable companies with sustainable value. Epassi Group is Europe’s leading digital solution for employee benefits, with a reach of nearly 13 million users, over 13 500 employers, and more than 59 000 service providers. Epassi is a market leader in the provision of digital employee benefits within the Nordics, Italy and the UK and has been awarded by the Financial Times as one of the fastest growing companies in Europe in 2022 and 2023.

Vinge's team consisted mainly of Sofie Nordgren, Niklas Törnell and Emil Sandgrim.

Full pressrelease 

Related

Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023